Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05389982 · ClinicalTrials.gov registry record · NA

Mobile Health Platform for Surveillance of Kidney Stone

A NA study, sponsored by Northwestern University.

Terminated
Registry status
NA
Development phase
75
Enrollment target

NCT05389982: Clinical Trial NA study, sponsored by Northwestern University.

NCT05389982 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05389982, a NA study, was terminated before completion, sponsored by Northwestern University.

TERMINATED
Registry status
NA
Development phase
75 participants
Enrollment target

Study Summary

We plan to investigate whether usage of a mobile health platform for surveillance of stone formers by itself or as an adjunct to standard office-appointments will improve patient compliance and adherence to treatment guidelines and ultimately improve patient care, satisfaction, quality of life, and decrease stone recurrence.

Primary Outcome

assess this using the validated Wisconsin Stone Quality of Life questionnaire

Interventions

  • OTHER Standard Care
  • OTHER mHealth (GetWell)

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2022-08-01
Est. Completion 2024-12-31
Phase NA
Northwestern University

1,209 total trials

Why NCT05389982 stopped before completion

NCT05389982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.

NCT05389982 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05389982 about?

NCT05389982 is a clinical study titled "Mobile Health Platform for Surveillance of Kidney Stone". We plan to investigate whether usage of a mobile health platform for surveillance of stone formers by itself or as an adjunct to standard office-appointments will improve patient compliance and adherence to treatment guidelines and ultimately improve patient care, satisfaction, quality of life, and ...

What is the current status of trial NCT05389982?

This trial is currently terminated. It is a NA study. The enrollment target is 75 participants. The study started on 2022-08-01. Estimated completion is 2024-12-31.

What interventions are being tested in trial NCT05389982?

The interventions under investigation include: Standard Care (OTHER), mHealth (GetWell) (OTHER).

Who is sponsoring clinical trial NCT05389982?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05389982's enrollment target sits among peer trials

75 1069th of 2000 higher than 919 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05389982, the US trial registry maintained by the National Library of Medicine. NCT05389982 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.